Uroporphyrin accumulation produced by halogenated biphenyls in chick-embryo hepatocytes. Reversal of the accumulation by piperonyl butoxide
- 1 July 1986
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 237 (1) , 63-71
- https://doi.org/10.1042/bj2370063
Abstract
Cultures of chick-embryo hepatocytes were used to study the mechanism by which 3,4,3'',4''-tetrachlorobiphenyl and 2,4,5,3'',4''-pentabromobiphenyl cause accumulation of uroporphyrin. In a previous paper, an isoenzyme of cytochrome P-450 induced by 3-methylcholanthrene had been implicated in this process [Sinclair, Bement, Bonkovsky and Sinclair (1984) Biochem. J. 222, 737-748]. Cells treated with 3,4,3'',4''-tetrachlorobiphenyl and 5-aminolaevulinate accumulated uroporphyrin and heptacarboxyporphyrin, whereas similarly treated cells accumulated protoporphyrin immediately after piperonyl butoxide was added. Piperonyl butoxide also restored haem synthesis as detected by incorporation of radioactive 5-aminolaevulinate into haem, and decrease in drug-induced 5-aminolaevulinate synthase activity. The restoration of synthesis of protoporphyrin and haem by piperonyl butoxide was not affected by addition of cycloheximide, indicating recovery was probably not due to protein synthesis de novo. Piperonyl butoxide also reversed uroporphyrin accumulation caused by 3,4,5,3'',4'',5''-hexachlorobiphenyl, mixtures of other halogenated biphenyls, lindane, parathion, nifedipine and verapamil. The effect of piperonyl butoxide was probably not due to inhibition of metabolism of these compounds, since the hexachlorobiphenyl was scarcely metabolized. Other methylenedioxyphenyl compounds, as well as ellipticine and acetylaminofluorene, also reversed the uroporphyrin accumulation caused by 3,4,3'',4''-tetrachlorobiphenyl. SKF-525A (2-dimethylaminoethyl-2,2-diphenyl valerate) did not reverse the uroporphyrin accumulation caused by the halogenated biphenyls, but did reverse that caused by phenobarbital and propylisopropylacetamide. We conclude that the mechanism of the uroporphyrin accumulation cannot be due to covalent binding of activated metabolites of halogenated compounds to uroporphyrinogen decarboxylase.This publication has 43 references indexed in Scilit:
- Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential decarboxylations of uroporphyrinogens I and III.Journal of Biological Chemistry, 1983
- Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzeneBiochemical and Biophysical Research Communications, 1982
- Porphyria Cutanea TardaSeminars in Liver Disease, 1982
- Decrease in hepatic cytochrome P-450 by cobalt. Evidence for a role of cobalt protoporphyrinBiochemical Journal, 1982
- Effects of dietary antioxidants on the biotransformation and porphyrinogenic action of hexachlorobenzene in two strains of ratsChemico-Biological Interactions, 1981
- Ethanol-mediated increase in cytochrome p-450 in cultured hepatocytesBiochemical Pharmacology, 1981
- Biotransformation and porphyrinogenic action of hexachlorobenzene and its metabolites in a primary liver cell cultureToxicology, 1981
- Inhibitors of Cytochrome P-450s and Their Mechanism of ActionDrug Metabolism Reviews, 1981
- Investigations on the presence of porphyrinogen carboxy-lyase inhibitor in the liver of rats intoxicated with hexachlorobenzeneInternational Journal of Biochemistry, 1980
- Metabolism as a prerequisite for the porphyrinogenic action of polyhalogenated aromatics, with special reference to hexachlorobenzene and polybrominated biphenyls (Firemaster BP-6)International Journal of Biochemistry, 1980